Tuberous sclerosis complex is associated with a novel human tauopathy Ji-Hye L. HwangOlga S. PerloffWilliam W. Seeley Original Paper 05 December 2022 Pages: 1 - 12
Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation Karin M. ForsbergKarin S. GraffmoPeter M. Andersen Original Paper Open access 16 November 2022 Pages: 13 - 28
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation Yoon A. KimTohid SiddiquiIsmael Santa-Maria Original Paper Open access 10 November 2022 Pages: 29 - 48
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification Michaela-Kristina KeckMartin SillDavid T. W. Jones Original Paper Open access 27 November 2022 Pages: 49 - 69
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1 Patrick J. CiminoCourtney KetchumKenneth Aldape Original Paper 22 October 2022 Pages: 71 - 82
Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours Alice MétaisYassine BouchouchaArnault Tauziède-Espariat Original Paper Open access 20 October 2022 Pages: 83 - 95
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts Martin MynarekDenise ObrechtTill Milde Original Paper Open access 02 December 2022 Pages: 97 - 112
Neuropathology of central nervous system involvement in TTR amyloidosis Ricardo TaipaLuísa SousaTeresa Coelho Original Paper Open access 06 October 2022 Pages: 113 - 126
Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure Conrad C. WeihlAna TöpfVolker Straub Original Paper 20 October 2022 Pages: 127 - 143
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials Nicholas G. Gottardo Correspondence Open access 20 November 2022 Pages: 145 - 147
NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target L. S. Hiemcke-JiwaM. T. MeisterL. A. Kester Correspondence Open access 04 November 2022 Pages: 149 - 152
Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement Gábor BedicsMonika CsókaBálint Scheich Correspondence Open access 23 November 2022 Pages: 153 - 156
Correction to: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease YuHong FuLiche ZhouGlenda M. Halliday Correction Open access 27 November 2022 Pages: 157 - 157